SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Organogenesis Holdings Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of February 8, 2022 - ORGO

PR Newswire

NEW YORK, Jan. 27, 2022

NEW YORK, Jan. 27, 2022 /PRNewswire/ -- The following statement is being issued by Levi & Korsinsky, LLP:

To: All persons or entities who purchased or otherwise acquired securities of Organogenesis Holdings Inc. ("Organogenesis" or the "Company") (NASDAQ: ORGO) between March 17, 2021 and October 11, 2021. You are hereby notified that a securities class action lawsuit has been commenced in the United States District Court for the Eastern District of New York. To get more information go to:

https://www.zlk.com/pslra-1/organogenesis-holdings-inc-loss-submission-form?prid=22629&wire=4

or contact Joseph E. Levi, Esq. either via email at [email protected] or by telephone at (212) 363-7500.There is no cost or obligation to you.

Organogenesis Holdings Inc. NEWS - ORGO NEWS

CASE DETAILS: According to the filed complaint: (i) Organogenesis improperly billed the federal government for its Affinity and PuraPly XT products by, among other things, setting the price for those products multiple times higher than similar products; (ii) the Company improperly induced doctors to use its Affinity and PuraPly XT products through lucrative reimbursements; (iii) as a result of all the foregoing, the Company's revenue and profits derived from its Affinity and PuraPly XT products were at least in substantial part unsustainable; and (iv) as a result, the Company's public statements were materially false and misleading at all relevant times.

WHAT THIS MEANS TO SHAREHOLDERS: If you suffered a loss in Organogenesis, you have until February 8, 2022 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.

NO COST TO YOU: If you purchased Organogenesis securities between March 17, 2021 and October 11, 2021, you may be entitled to compensation without payment of any out-of-pocket costs or fees.

PROTECT YOUR FINANCIAL INTERESTS: Complete this brief submission form https://www.zlk.com/pslra-1/organogenesis-holdings-inc-loss-submission-form?prid=22629&wire=4 or call 212-363-7500 to discuss the case with Joseph E. Levi, Esq.

WHY LEVI & KORSINSKY: Over the past 20 years, the team at Levi & Korsinsky has secured hundreds of millions of dollars for aggrieved shareholders and built a track record of winning high-stakes cases. Our firm has extensive expertise representing investors in complex securities litigation and a team of over 70 employees to serve our clients. For seven years in a row, Levi & Korsinsky has ranked in ISS Securities Class Action Services' Top 50 Report as one of the top securities litigation firms in the United States.

CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
Ed Korsinsky, Esq.
55 Broadway, 10th Floor
New York, NY 10006
[email protected]
Tel: (212) 363-7500
Fax: (212) 363-7171
www.zlk.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/shareholder-alert-levi--korsinsky-llp-reminds-shareholders-of-organogenesis-holdings-inc-of-a-class-action-lawsuit-and-a-lead-plaintiff-deadline-of-february-8-2022--orgo-301470360.html

SOURCE Levi & Korsinsky, LLP